| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 03/07/2007 | CN1926112A Novel difluoroethoxy-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors |
| 03/07/2007 | CN1926111A Novel isoamido-substituted hydroxy-6-phenylphenanthridines |
| 03/07/2007 | CN1926110A Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors |
| 03/07/2007 | CN1923815A Synthesis method of lappaconitine hydrobromide |
| 03/07/2007 | CN1923814A Synthesis method of lappaconitine citrate |
| 03/07/2007 | CN1923813A Aporphine and use of oxidized aporphine alkaloid |
| 03/07/2007 | CN1303083C 红色有机电致发光材料 Red organic electroluminescent material |
| 03/07/2007 | CN1303082C 3-phenyl-3.7-diazobicyclo [3,3,1] nonane compound and its preparation method and medicine containing it |
| 03/07/2007 | CN1303059C Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 03/06/2007 | US7186870 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 03/06/2007 | US7186844 Alkyl- or phenyl-substituted 2-oxazolidinones; reacting a dihalo compound with a primary amine and carbon dioxide; nontoxic; industrial scale |
| 03/06/2007 | US7186838 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 03/06/2007 | US7186728 Methylene-4-azasteroids |
| 03/01/2007 | WO2005117876A8 Dual small molecule inhibitors of cancer and angiogenesis |
| 03/01/2007 | US20070049613 cis-6-(2,4-Dichloro-phenyl)-1,2,3,4,4a,9a-hexahydro-3-aza-fluoren-9-one, used for treating metabolic disorders, nervous system disorders, headaches, gastrointestinal disorders and as analgesics |
| 03/01/2007 | CA2620052A1 Indenoisoquinolinone analogs and methods of use thereof |
| 02/28/2007 | EP1756101A2 Androgen receptor modulators and method of treating disease using the same |
| 02/28/2007 | EP1756063A1 Amido compounds and their use as pharmaceuticals |
| 02/28/2007 | EP1465893B1 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo (3.2.1) octane, the preparation thereof and the application of same in therapeutics |
| 02/28/2007 | EP1418912B1 Isoxazolopyridinones |
| 02/28/2007 | EP1309592B9 Substituted pyrazoles |
| 02/28/2007 | CN1922146A Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors |
| 02/28/2007 | CN1301997C Benzosulfones with calcium antagonist activity |
| 02/27/2007 | US7183413 Aminoquinoline compounds |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183313 Keto cannabinoids with therapeutic indications |
| 02/27/2007 | US7183282 N'-methyl-2-[(p-fluorophenyl)-4-oxo-butyl]piperazino[1,2-fg]gamma-carboline; N'-methyl-2-[p-fluorophenoxypropyl]piperazino[1,2-fg]gamma-carboline; serotonin modulators; sleep disorders; central nervous system disorders |
| 02/22/2007 | WO2007020636A1 Printable materials |
| 02/22/2007 | WO2007019942A1 Metal complex |
| 02/22/2007 | WO2007019752A1 Process for the preparation of gabapentin hydrochloride |
| 02/22/2007 | WO2006059103A3 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
| 02/21/2007 | EP1754707A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 02/21/2007 | EP1753740A2 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
| 02/21/2007 | EP1753713A2 Synthesis of tetracyclines and analogues thereof |
| 02/21/2007 | EP1539703A4 Method for the selective preparation of 3-oxo-4-aza-5a-androstane compound |
| 02/21/2007 | CN1918161A Tricyclic imidazopyridines and intermediates for the synthesis thereof |
| 02/21/2007 | CN1918160A Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
| 02/21/2007 | CN1916760A Acid-producing agent, sulfonic acid, sulfonic acid derivative and radiation-sensitive resin composition |
| 02/21/2007 | CN1916629A Fluorescence carrier in use for preparing sensor in use for mensurating content of water in organic solvent |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/15/2007 | WO2007018168A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 02/15/2007 | CA2617473A1 Acylguanidine derivative or salt thereof |
| 02/14/2007 | EP1751165A1 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones |
| 02/14/2007 | EP1750706A1 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/14/2007 | EP1560828B9 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 02/14/2007 | CN1914205A Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
| 02/14/2007 | CN1911933A Oxygen, nitrogen heterocyclic naphthoyl imine kind compound and its bioapplication |
| 02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
| 02/14/2007 | CN1911928A Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics |
| 02/14/2007 | CN1300147C Camptothecin derivatives preparing process |
| 02/14/2007 | CN1300146C Photochromic compound of spiro [indolerin-phenanthroline oxazine and its preparation and use |
| 02/14/2007 | CN1300140C Compound of quinacridones-carbazole group and application in organic electroluminescence device |
| 02/13/2007 | US7176255 Emulsion polymerized colored addition polymers using an oil in water emulsion containing in the dispersed phase and oil-soluble unsaturated dye in droplet form having diameters of dz < 1000; whiteness requires a much lower amount of water-soluble optical brightener in the case of paper coating slips |
| 02/13/2007 | US7176198 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
| 02/08/2007 | WO2007016029A2 Diazepinoquinolines, synthesis thereof, and intermediates thereto |
| 02/08/2007 | WO2007014902A2 Multiple chromophores based on rylene |
| 02/08/2007 | DE102005037115A1 Mehrfachchromophore Polychromophores |
| 02/08/2007 | CA2616161A1 Diazepinoquinolines, synthesis thereof, and intermediates thereto |
| 02/07/2007 | EP1749316A2 Perylene n-type semiconductors and related devices |
| 02/07/2007 | EP1749005A1 Tetrahydro-imidazo ¬1,5-a| pyridin derivatives as aldosterone synthase inhibitors |
| 02/07/2007 | EP1536798B1 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| 02/07/2007 | EP1242382B1 Tricyclic protein kinase inhibitors |
| 02/07/2007 | CN1910167A Selective estrogen receptor modulators for the treatment of vasomotor symptoms |
| 02/07/2007 | CN1910155A Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis |
| 02/07/2007 | CN1907974A Huperzine with analgesic function and derivative thereof |
| 02/07/2007 | CN1907973A Process for preparing 2,3-cyclopentene pyridine |
| 02/07/2007 | CN1298720C Sinomenine derivative with C cycle connected to penetabasic heterocycle and synthesizing method |
| 02/07/2007 | CN1298718C Derivative of sinomenine with pyrazinc cyclc being connected to C cycle, synthetic method and application |
| 02/07/2007 | CN1298717C Quinuclidine carbamate derivatives and their use as M3 antigonists |
| 02/01/2007 | US20070027177 11-(3-fluorophenyl)-9-methoxy-3,4-dihydro-2H-pyrido[1,2-b]isoquinoline-1,6-dione, used as antiarrhythmia agents |
| 02/01/2007 | US20070027156 Crf antagonists and heterobicyclic compounds |
| 02/01/2007 | CA2615774A1 Large substituent, non-phenolic opioids |
| 01/31/2007 | EP1747200A1 Alkaloid compounds and their use as anti-malarial drugs |
| 01/31/2007 | CN1906200A Novel compounds |
| 01/31/2007 | CN1905873A Bicyclic inhibitors of MEK and methods of use thereof |
| 01/31/2007 | CN1297557C Preparation of spirocyclic template compound |
| 01/31/2007 | CN1297556C New benzo[b]chromeno-naphthyridin-7-one and pyrano[2',3':7,8] quino[2,3-b]quinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/31/2007 | CN1297554C Amido ether substituted imidazoquinolines |
| 01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 01/30/2007 | CA2440383C 7,9-substituted tetracycline compounds |
| 01/25/2007 | WO2006114676A3 A process for the preparation of rupatadine |
| 01/25/2007 | WO2006098855A3 Processes for preparing morphinans and intermediates thereof |
| 01/25/2007 | WO2005025556A3 Antibiotic cycloalkyltetrahydroquinoline derivatives |
| 01/25/2007 | US20070021606 Therapeutic compounds |
| 01/25/2007 | US20070021457 analgesics, antidiarrheal agents, anticonvulsants, antitussives, anti-addiction; 8-Substituted-2,6-methano-3-benzazocines |
| 01/25/2007 | US20070021455 Process for the preparation of finasteride form i |
| 01/24/2007 | EP1745025A2 Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors |
| 01/24/2007 | EP1744758A2 Radiopharmaceutical and methods of synthesis and use thereof |
| 01/24/2007 | CN1902200A 1h-imidazoquinoline derivatives as protein kinase inhibitors |
| 01/24/2007 | CN1902180A Use of 4-cyano-naphthalene-1,8-dicarboximide derivatives and related compounds to protect organic material from the damaging effects of light |
| 01/24/2007 | CN1900077A New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
| 01/24/2007 | CN1296360C (1R,2R) or (1S,2S)-1-(4'-substitute-1'8'-naphthoyl imdo group)-2-amino cyclohexane, preparation and application |
| 01/23/2007 | US7166726 Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 01/23/2007 | US7166600 Resistant to metabolism, improved half-life and/or clearance properties compared to corresponding carbamates; e.g N-(2-chlorobenzoyl)-p-(morpholinothiocarbonyloxy)tyrosine; used to treat inflammatory diseases e.g rheumatoid arthritis, asthma, psoriasis, multiple sclerosis, inflammatory bowel disease |
| 01/23/2007 | US7166596 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/18/2007 | US20070015775 Heterocyclic compounds |
| 01/18/2007 | US20070015751 Nitro and amino substituted heterocycles as topoisomerase I targeting agents |
| 01/18/2007 | CA2612841A1 Inhibitors of checkpoint kinases |